Possibility of a new functional food component from soybeans
Possibility of a new functional food component from soybeans
批准号:
18500618
负责人:
YANO Tomohiro
金额:
$2.61万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The present study was designed to investigate the effects of Bowman-Birk inhibitor concentrate(BBIC) from soybean on anti-proliferation, up-regulation of Connexin (Cx) 43 expression and inhabitation of hepatic metastasis in mice with M5076 ovarian sarcoma. M5076 ovarian sarcomas (1×10^6 cells/animal) were subcutaneously transplanted into the back of BDF_1 mice. "Pre-treated group" (n=10) and "post-treated group" (n=10) were fed with standard diet (CE-2, Crea Japan) compounded 0.5%-1% BBI from 3 weeks before and at the day of tumor inoculation until the weeks after tumor inoculation, respectively. "Control group" (n=10) was fed with CE-2 alone. The relative tumor weights in the pre- (0.013±0.010) and post- (0.012±0.013) treated groups were significantly reduced by 30.0% and 32.5% compared with that in the control group (0.040±0.022, p<0.01), respectively. The relative densities of Cx43-mRNA and Cx43 proteins in the BBIC treated groups were significantly higher than that in the control group. The median numbers of macroscopic spontaneous metastases in the pre- (1.0±2.3) and post-(1.9±3.6) treated groups were significantly lower than that in the control group (71.4±97.3), and, respectively. These results suggested that BBIC induced anti-proliferation caused by the expression of Cx43 genes in mice with M5076 ovarian sarcoma. In addition, BBIC inhibited the hepatic metastasis in M5076 bearing mice. Overall, It seems that BBI is a promising candidate to prevent the development of tumors in which Cx43 acts as a tumor suppressor gene.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
A New Mechanism on Anti-carcinogenic Effect of Bowman-Birk Protease Inhibitor(BBI) from Soybeans
大豆鲍曼-伯克蛋白酶抑制剂(BBI)抗癌新机制
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Yano T, Saito T, Kashiwagi K, Hagiwara H, Sato H]
通讯作者:
Sato H
DOI:
10.1016/j.canlet.2007.01.021
发表时间:
2007-08
期刊:
Cancer letters
影响因子:
9.7
作者:
[Teruyoshi Saito;Hiromi Sato;N. Virgona;H. Hagiwara;K. Kashiwagi;Kazuyuki Suzuki;R. Asano;T. Yano]
通讯作者:
Teruyoshi Saito;Hiromi Sato;N. Virgona;H. Hagiwara;K. Kashiwagi;Kazuyuki Suzuki;R. Asano;T. Yano
New Mechanism on Anti-carcinogenic Effect of Bowman-Birk Protease Inhibitor (BBI) from Soybeans
大豆鲍曼-伯克蛋白酶抑制剂(BBI)抗癌新机制
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Yano T, Saito T, Kashiwagi K, Hagiwara H, Sato H]
通讯作者:
Sato H
がん抑制遺伝子(コネキシン43)の発現・機能回復による中皮腫発生抑制に関する研究-大豆由来のBowman-Birk protease inhibitorを用いた検討-
通过肿瘤抑制基因(连接蛋白43)的表达和功能恢复来抑制间皮瘤发展的研究 - 使用源自大豆的 Bowman-Birk 蛋白酶抑制剂的研究 -
DOI:
--
发表时间:
2007
期刊:
大豆たん白質研究 10
影响因子:
--
作者:
[矢野友啓, 柏木維人, 佐藤洋美]
通讯作者:
佐藤洋美
The effects of Bowman-Birk Protease inhibitor concentrate BBIC) on anti-proliferation and inhbition of metastasis in M5076 bearing mice.
Bowman-Birk 蛋白酶抑制剂浓缩物 BBIC) 对携带 M5076 的小鼠的抗增殖和抑制转移的作用。
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[Sano Y, Yoshimura H, Nishimura Y, Sakurai N, Suzuki , Yano T]
通讯作者:
Yano T
共 13 条
Bioavailability evaluation on a new food component from soybeans
-
批准号:22500754
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.66万
-
财政年份:2010
-
负责人:YANO Tomohiro
-
依托单位:
Determination of connexin gene contributing to suppression of canine mammary carcinogenesis and investigation of the mechanism
-
批准号:16580259
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2004
-
负责人:YANO Tomohiro
-
依托单位:
THE ESTIMATION OF A USEFUL LEVEL OF VITAMINE INTAKE AGAINST THE PREVENTION OF LUNG ADENOCARCINOMA
-
批准号:07680075
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1995
-
负责人:YANO Tomohiro
-
依托单位:
国内基金
海外基金
大豆BBI 基纳米载体输送疏水性生物活性物质的机理研究
-
批准号:2019JJ40536
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2019
-
负责人:刘春
-
依托单位:
胰蛋白酶抑制剂BBI通过RIP3激活线粒体途径诱导肿瘤细胞凋亡的机制研究
-
批准号:31271476
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:龙民慧
-
依托单位:
大豆蛋白酶抑制物BBI对食管癌的抗癌及其机理的研究
-
批准号:38970815
-
项目类别:面上项目
-
资助金额:3.0万元
-
批准年份:1989
-
负责人:谭润生
-
依托单位: